IonSource Daily Links to 
Mass Spectrometry, Biotechnology and Pharmaceutical  Industry News

 

IonSource Home | Disclaimer

Note: News stories may be minutes or several days old and should not be used for investment purposes.

-

-
-
04/21/11 Pfizer Comments on ORAL Sync Tofacitinib Data in EULAR Abstract LB0005
   
  FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
   
  Merck and Sanofi Pasteur Initiate Phase III Study in the United States of Pediatric Combination Vaccine to Help Prevent Six Infectious Diseases
   
04/20/11 FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer
   
  Pfizer and Shanghai Pharmaceutical Sign Memorandum of Understanding for Potential Strategic Partnership
   
  Gilead and MicroDose Therapeutx Announce License and Collaboration Agreement to Develop MDT-637 for Treatment of Respiratory Syncytial Virus
   
  Amgen's First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
   
  Abbott Reports 17.4 Percent Sales Growth and 12.3 Percent Ongoing Earnings-Per-Share Growth in First Quarter
   
04/19/11 Sangamo BioSciences Announces First Quarter 2011 Conference Call and Webcast
   
  Novartis generates strong sales growth of 14% in constant currencies in first quarter, operating income impacted by 2010 sales from A(H1N1) pandemic flu vaccines
   
  Genentech: FDA Approves Rituxan Plus a Steroid for Use in Severe Forms of Vasculitis
   
  Biogen_Idec FDA Approves Rituxan Plus a Steroid for Use in Severe Forms of Vasculitis
   
  Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN
   
04/18/11 FDA approves Actemra for the treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
   
  GSK welcomes key agreement to support global preparedness against pandemic influenza
   
  Lilly Declares Second-Quarter 2011 Dividend
   
04/15/11 Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic Insufficiency
   
  Genentech: FDA Approves ACTEMRA® (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
   
  Regulatory Update: GlaxoSmithKline submits additional information for candidate meningococcal and Hib combination vaccine
   
  Merck Commences Tender Offer for all Outstanding Shares of Inspire Pharmaceuticals, Inc.
   
  Roche gains positive CHMP opinion for the combination of Avastin with Xeloda as a first-line treatment for metastatic breast cancer in Europe
   
  Pfizer Announces Top-Line Results Of Third Phase 3 Clinical Trial Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis
   
  AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation
   
  Merck Commences Tender Offer for all Outstanding Shares of Inspire Pharmaceuticals, Inc.
   

Company News

 On-Line Magazines Hot News Sites
Abbott
Agilent
Amgen
Applied Bio.
Bayer
Biogen_Idec
BioMarin
Bruker
BMS Company
 Caliper
DepoMed
Vermillion		 Novartis Diag.
Compugen
Eli Lilly
Genentech
Geron
Gilead
GSK
 Incyte Gen.
Life Technologies
Leap Tech.
Nordion
Maxygen


 		Merck
Millennium
Myriad
Nektar
Novartis
Pfizer
Roche
Sangamo
Shimadzu
Telik
ThermoElectron
 		LCGC Magazine
 Drug Discovery and Development Magazine
 New Scientist

Proteomic Company News Links
 Check out the Proteomics page at IonSource 

BioWire2K
 Coranate
FierceBiotech
GenomeWeb
 GE News of the Day
 Moreover
ScienceNews On-Line
 The Seattle Times
SF Gate Technology News

 

Archive of old news 

home | disclaimer
Copyright © 2001-2016  IonSource, LLC  All rights reserved. 
Last updated:  Tuesday, January 19, 2016 02:50:53 PM

Hit Counter